Home › Viral Infections › New York
Viral Infections clinical trials in New York
7 studies for Viral Infections are looking for participants at sites in New York.
Cities in New York
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Buffalo
- Research Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05624450Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- NYU Langone Health, New York
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07654283A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- NYC Health + Hospitals/Lincoln Medical Center - BRANY - PPDS, The Bronx
- Prime Global Research, Inc., The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07214571A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Upstate Global Health Institute, East Syracuse
- Upstate Connect Care, Syracuse
- Prime Global Research, The Bronx
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 15, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- NYU Langone Health, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07013474Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- New York Medical College, Vallhala
RecruitingPhase 1/2
1 Month – 79 Years · All sexes · Updated Apr 15, 2026 · NCT04197596Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
- Montefiore Medical Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT07110636From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.